US5688819A
(en)
*
|
1992-09-21 |
1997-11-18 |
Allergan |
Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
|
US5972991A
(en)
*
|
1992-09-21 |
1999-10-26 |
Allergan |
Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
US6184250B1
(en)
|
1993-08-03 |
2001-02-06 |
Alcon Laboratories, Inc. |
Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
|
US5510383A
(en)
*
|
1993-08-03 |
1996-04-23 |
Alcon Laboratories, Inc. |
Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
|
WO1997023225A1
(en)
*
|
1995-12-22 |
1997-07-03 |
Alcon Laboratories, Inc. |
Combinations of dp and fp type prostaglandins for lowering iop
|
EP0930296B2
(en)
*
|
1996-09-17 |
2005-11-02 |
Asahi Glass Company Ltd. |
Fluorinated prostaglandin derivatives and medicines
|
JP2001504100A
(ja)
*
|
1996-11-01 |
2001-03-27 |
アルコン・ラボラトリーズ・インコーポレーテッド |
緑内障を治療するための炭酸脱水素酵素阻害剤とプロスタグランジンとの組合せの使用
|
US6680339B2
(en)
|
1996-11-12 |
2004-01-20 |
Alcon Manufacturing, Ltd. |
15-fluoro prostaglandins as ocular hypotensives
|
JP4248022B2
(ja)
*
|
1996-11-12 |
2009-04-02 |
アルコン ラボラトリーズ,インコーポレイテッド |
眼圧降下剤としての15―フルオロプロスタグランジン
|
WO1998020880A2
(en)
*
|
1996-11-12 |
1998-05-22 |
Alcon Laboratories, Inc. |
11-halo prostaglandins for the treatment of glaucoma or ocular hypertension
|
JP3480549B2
(ja)
*
|
1996-12-26 |
2003-12-22 |
参天製薬株式会社 |
ジフルオロプロスタグランジン誘導体およびその用途
|
PL339212A1
(en)
*
|
1997-09-09 |
2000-12-04 |
Procter & Gamble |
Aromatic c16-c20-substituted tetrahydroprostaglandines useful as fp agonists
|
SK3382000A3
(en)
*
|
1997-09-09 |
2000-10-09 |
Procter & Gamble |
A compound having structure of aromatic substituted prostaglandins and its use for the treatment of bone disorders
|
US6066671A
(en)
|
1997-12-19 |
2000-05-23 |
Alcon Laboratories, Inc. |
Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
|
US6646001B2
(en)
|
1997-12-19 |
2003-11-11 |
Alcon Manufacturing, Ltd. |
Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
|
US6225348B1
(en)
|
1998-08-20 |
2001-05-01 |
Alfred W. Paulsen |
Method of treating macular degeneration with a prostaglandin derivative
|
JP4834224B2
(ja)
|
1999-03-05 |
2011-12-14 |
デューク ユニバーシティ |
C16不飽和fp−選択的プロスタグランジン類縁体
|
US6294679B1
(en)
*
|
1999-04-12 |
2001-09-25 |
Chirotech Technology Limited |
Intermediate for the synthesis of prostaglandins
|
US6214611B1
(en)
|
1999-04-12 |
2001-04-10 |
Chirotech Technology Limited |
Process for the preparation of prostaglandin precursors
|
GB9908326D0
(en)
*
|
1999-04-12 |
1999-06-09 |
Chirotech Technology Ltd |
Novel process intermediate for the synthesis of prostaglandins
|
US6894175B1
(en)
*
|
1999-08-04 |
2005-05-17 |
The Procter & Gamble Company |
2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
|
JP4000505B2
(ja)
|
1999-12-01 |
2007-10-31 |
第一三共株式会社 |
緑内障を治療するための併用剤
|
AU2001228836A1
(en)
*
|
2000-01-28 |
2001-08-07 |
Santen Pharmaceutical Co., Ltd. |
Novel difluoroprostaglandin derivative
|
JP2003531824A
(ja)
|
2000-02-01 |
2003-10-28 |
ケイマン ケミカル カムパニー,インク. |
フルプロステノールおよび関連プロスタグランジンF2α類似体の内部1,15−ラクトン、ならびに緑内障および眼高血圧の治療におけるそれらの使用
|
US7012090B1
(en)
|
2000-03-17 |
2006-03-14 |
Alcon, Inc. |
Pyranoindoles for treating glaucoma
|
US6927233B1
(en)
|
2000-03-17 |
2005-08-09 |
Alcon, Inc. |
5ht2 agonists for controlling IOP and treating glaucoma
|
US20030119846A1
(en)
*
|
2000-03-17 |
2003-06-26 |
Collier Jr Robert J. |
Compounds with 5-ht activity useful for controlling visual field loss
|
US7005443B1
(en)
|
2000-03-17 |
2006-02-28 |
Alcon, Inc. |
5-Hydroxy indazole derivatives for treating glaucoma
|
US6660870B1
(en)
|
2000-03-17 |
2003-12-09 |
Alcon, Inc. |
2-acylaminobenzimidazole derivatives for treating glaucoma
|
US6806285B1
(en)
|
2000-03-17 |
2004-10-19 |
Alcon, Inc. |
5-Hydroxyl indole derivatives for treating glaucoma
|
US6956036B1
(en)
|
2000-03-17 |
2005-10-18 |
Alcon, Inc. |
6-hydroxy-indazole derivatives for treating glaucoma
|
US20020172693A1
(en)
*
|
2000-03-31 |
2002-11-21 |
Delong Michell Anthony |
Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
|
US20020146439A1
(en)
*
|
2000-03-31 |
2002-10-10 |
Delong Mitchell Anthony |
Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
|
US20020013294A1
(en)
*
|
2000-03-31 |
2002-01-31 |
Delong Mitchell Anthony |
Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
|
US20020037914A1
(en)
*
|
2000-03-31 |
2002-03-28 |
Delong Mitchell Anthony |
Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
|
PE20020146A1
(es)
*
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
|
WO2004098807A1
(en)
*
|
2000-11-21 |
2004-11-18 |
Barsplice Products, Inc. |
Method of making steel couplers for joining concrete reinforcing bars
|
SE0100158D0
(sv)
*
|
2001-01-19 |
2001-01-19 |
Synphora Ab |
Novel method and composition for local treatment of Meniere´s disease and tinnitus
|
US20050171054A1
(en)
*
|
2001-01-19 |
2005-08-04 |
Helge Rask-Andersen |
Novel method and composition for local treatment of meniere's disease, tinnitus and/or hearing loss
|
US20040198829A1
(en)
*
|
2001-04-23 |
2004-10-07 |
Sponsel William Eric |
Prostanoids augment ocular drug penetration
|
US20030212107A1
(en)
*
|
2001-05-10 |
2003-11-13 |
Kapin Michael A. |
R-reliprodil for treating glaucoma
|
GB0112699D0
(en)
*
|
2001-05-24 |
2001-07-18 |
Resolution Chemicals Ltd |
Process for the preparation of prostglandins and analogues thereof
|
WO2002098860A1
(en)
*
|
2001-06-01 |
2002-12-12 |
Alcon, Inc. |
Novel fused indazoles and indoles and their use for the treatment of glaucoma
|
CN1512879A
(zh)
*
|
2001-06-01 |
2004-07-14 |
�Ƹ��� |
新的芳氨基丙烷类似物及其用于治疗青光眼的用途
|
MXPA03010807A
(es)
*
|
2001-06-01 |
2004-11-22 |
Alcon Inc |
Piranoidazoles y su uso para el tratamiento del glaucoma.
|
US6884816B2
(en)
*
|
2001-08-31 |
2005-04-26 |
Alcon, Inc. |
Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma
|
US20040254230A1
(en)
*
|
2001-12-03 |
2004-12-16 |
Ogidigben Miller J. |
Method for treating ocular hypertension
|
US7351404B2
(en)
*
|
2002-02-04 |
2008-04-01 |
Allergan, Inc. |
Method of enhancing hair growth
|
US9216183B2
(en)
|
2002-02-04 |
2015-12-22 |
Allergan, Inc. |
Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
|
US8758733B2
(en)
|
2002-02-04 |
2014-06-24 |
Allergan, Inc. |
Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
|
US20040110776A1
(en)
*
|
2002-02-22 |
2004-06-10 |
Iok-Hou Pang |
Use of propentofylline to control intraocular pressure
|
US20060264353A1
(en)
*
|
2002-03-21 |
2006-11-23 |
Maxey Kirk M |
Prostaglandin f2alpha analogs and their use in combination with antimicrobial proteins for the treatment of glaucoma and intraocular hypertension
|
JP4766875B2
(ja)
|
2002-06-06 |
2011-09-07 |
メルク フロスト カナダ リミテツド |
Ep4受容体作動薬、組成物及びその方法
|
WO2003103664A1
(en)
*
|
2002-06-06 |
2003-12-18 |
Merck Frosst Canada & Co. |
1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
|
US6864282B2
(en)
*
|
2002-08-05 |
2005-03-08 |
Allergan, Inc. |
9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
|
CA2495917A1
(en)
*
|
2002-08-28 |
2004-03-11 |
Merck Frosst Canada & Co. |
Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma
|
AU2003257588A1
(en)
*
|
2002-08-29 |
2004-03-19 |
Santen Pharmaceutical Co., Ltd. |
REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDINS
|
CA2495192A1
(en)
*
|
2002-08-30 |
2004-03-11 |
Alcon, Inc. |
Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
|
JP2006505572A
(ja)
*
|
2002-10-25 |
2006-02-16 |
メルク フロスト カナダ アンド カンパニー |
Ep4受容体アゴニストとしての2−ピロリドン
|
US7528163B2
(en)
*
|
2002-11-08 |
2009-05-05 |
Merck & Co. Inc. |
Ophthalmic compositions for treating ocular hypertension
|
US7196082B2
(en)
*
|
2002-11-08 |
2007-03-27 |
Merck & Co. Inc. |
Ophthalmic compositions for treating ocular hypertension
|
US20080004311A1
(en)
*
|
2002-11-12 |
2008-01-03 |
Alcon, Inc. |
Histone deacetylase inhibitors for treating degenerative diseases of the eye
|
EP1562592A4
(en)
*
|
2002-11-12 |
2009-01-21 |
Alcon Inc |
HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE EYE
|
WO2004045644A1
(ja)
|
2002-11-18 |
2004-06-03 |
Santen Pharmaceutical Co., Ltd. |
Rhoキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤
|
US7053085B2
(en)
*
|
2003-03-26 |
2006-05-30 |
Merck & Co. Inc. |
EP4 receptor agonist, compositions and methods thereof
|
MXPA05005937A
(es)
*
|
2002-12-06 |
2005-08-18 |
Alcon Inc |
Imitaciones de superoxido de dismutasa para el tratamiento de trastornos y enfermedades oculares.
|
MXPA05006277A
(es)
*
|
2002-12-13 |
2005-09-08 |
Alcon Inc |
Analogos de benzopirano novedosos y su uso para el tratamiento de glaucoma.
|
AR043161A1
(es)
*
|
2003-02-14 |
2005-07-20 |
Sucampo Pharmaceuticals Inc |
Composicion oftalmica para tratar hipertension ocular y glaucoma
|
EP1646614A4
(en)
*
|
2003-07-01 |
2008-09-10 |
Merck & Co Inc |
OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF OCCULAR HYPERTONIA
|
US20050119262A1
(en)
*
|
2003-08-21 |
2005-06-02 |
Pharmacia Corporation |
Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent
|
CA2537119A1
(en)
*
|
2003-09-02 |
2005-03-10 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
CN1842335A
(zh)
*
|
2003-09-04 |
2006-10-04 |
默克公司 |
用于治疗高眼压的眼用组合物
|
EP1663987B1
(en)
*
|
2003-09-04 |
2009-03-18 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
CA2536874A1
(en)
*
|
2003-09-05 |
2005-03-17 |
Novartis Ag |
Compositions comprising benzo (g) quinoline derivatives and prostaglandin derivatives
|
DE602004023106D1
(de)
*
|
2003-11-07 |
2009-10-22 |
Senju Pharma Co |
Pharmazeutische zusammensetzung mit prostaglandin
|
US7476687B2
(en)
*
|
2003-11-26 |
2009-01-13 |
Alcon, Inc. |
Substituted furo[2,3-g]indazoles for the treatment of glaucoma
|
US7129257B1
(en)
|
2003-12-15 |
2006-10-31 |
Alcon, Inc. |
Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
|
AR046890A1
(es)
*
|
2003-12-15 |
2005-12-28 |
Alcon Inc |
[1,4] oxazino [2,3-g] indazoles sustituidos para el tratamiento del glaucoma.
|
US7338972B1
(en)
|
2003-12-15 |
2008-03-04 |
Alcon, Inc. |
Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
|
GB0329620D0
(en)
*
|
2003-12-22 |
2004-01-28 |
Pharmagene Lab Ltd |
EP2 receptor agonists
|
JP2005263792A
(ja)
*
|
2004-02-19 |
2005-09-29 |
Santen Pharmaceut Co Ltd |
澄明なラタノプロスト点眼液
|
WO2005079809A1
(ja)
*
|
2004-02-19 |
2005-09-01 |
Santen Pharmaceutical Co., Ltd. |
澄明なラタノプロスト点眼液
|
ES2311986T3
(es)
*
|
2004-04-26 |
2009-02-16 |
Alcon, Inc. |
Estatinas para el tratamiento de la hipertension ocular y del glaucoma.
|
EP1771170A4
(en)
|
2004-07-20 |
2009-07-08 |
Merck & Co Inc |
OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF OCCULAR HYPERTONIA
|
CA2583593A1
(en)
*
|
2004-10-13 |
2006-04-27 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
JP2008515982A
(ja)
*
|
2004-10-13 |
2008-05-15 |
メルク エンド カムパニー インコーポレーテッド |
高眼圧症を治療するための眼科組成物
|
ATE412400T1
(de)
*
|
2004-11-09 |
2008-11-15 |
Novagali Pharma Sa |
Öl-in-wasser-emulsion mit niedriger konzentration des kationischen mittels und positivem zetapotential
|
US7425572B2
(en)
*
|
2004-12-08 |
2008-09-16 |
Alcon, Inc. |
Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
|
DK1846354T3
(da)
*
|
2005-01-14 |
2010-08-16 |
Allergan Inc |
Substituterede cyclopentaner eller cyclopentanoner til behandling af okular hypertensive tilstande
|
GB0501192D0
(en)
*
|
2005-01-20 |
2005-03-02 |
Resolution Chemicals Ltd |
Stable prostaglandin-containing compositions
|
US7851504B2
(en)
|
2005-03-16 |
2010-12-14 |
Allergan, Inc. |
Enhanced bimatoprost ophthalmic solution
|
US9241918B2
(en)
|
2005-03-16 |
2016-01-26 |
Allergan, Inc. |
Enhanced bimatoprost ophthalmic solution
|
US20090234005A1
(en)
|
2005-03-31 |
2009-09-17 |
Naruhiro Ishida |
Protective agent for retinal neuronal cell containing prostaglandin f2alpha derivative as active ingredient
|
KR20070119726A
(ko)
|
2005-04-13 |
2007-12-20 |
우베 고산 가부시키가이샤 |
인다졸 유도체를 유효 성분으로서 함유하는 망막신경세포보호제
|
US20060293378A1
(en)
*
|
2005-06-28 |
2006-12-28 |
Mcintire Gregory |
Method of lowering intraocular pressure
|
EP1912957A4
(en)
*
|
2005-08-03 |
2009-05-13 |
Merck Frosst Canada Ltd |
EP4 AGONIST RECEIVER, COMPOSITIONS AND METHODS RESULTING THEREFROM
|
TW200744567A
(en)
*
|
2005-09-23 |
2007-12-16 |
Alcon Inc |
Phenylethylamine analogs and their use for treating glaucoma
|
EP1810967B1
(en)
|
2006-01-18 |
2014-07-30 |
Chirogate International Inc. |
Processes and intermediates for the preparations of prostaglandins
|
WO2007091970A1
(en)
*
|
2006-02-06 |
2007-08-16 |
Synphora Ab |
Novel method and compositions for treatment of tinnitus
|
AU2007227664A1
(en)
*
|
2006-03-13 |
2007-09-27 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
CN104224704A
(zh)
*
|
2006-03-13 |
2014-12-24 |
株式会社·R-技术上野 |
水性组合物
|
WO2007111806A2
(en)
|
2006-03-23 |
2007-10-04 |
Massachusetts Eye And Ear Infirmary |
Cyclopentane heptanoic acid compounds for reducing body fat
|
US20090281154A1
(en)
*
|
2006-06-12 |
2009-11-12 |
Doherty James B |
Ophthalmic Compositions for Treating Ocular Hypertension
|
US8455513B2
(en)
|
2007-01-10 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-aminoisoquinoline compounds
|
UY30883A1
(es)
|
2007-01-31 |
2008-05-31 |
Alcon Res |
Tapones punctales y metodos de liberacion de agentes terapeuticos
|
AU2008220104B2
(en)
|
2007-02-28 |
2012-09-27 |
Asahi Kasei Pharma Corporation |
Sulfonamide derivative
|
US20090018204A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Brinkenhoff Michael C |
Composition and method for enhancing hair growth
|
EP2291346A2
(en)
*
|
2008-05-15 |
2011-03-09 |
Allergan, Inc. |
Therapeutic substituted cyclopentanes
|
US20080275118A1
(en)
*
|
2008-06-12 |
2008-11-06 |
Shaw Mari M |
Health and cosmetic composition and regime for stimulating hair growth and thickening on the head, including the scalp, eyelashes, and eyebrows, and which discourages hair loss
|
US8450344B2
(en)
|
2008-07-25 |
2013-05-28 |
Aerie Pharmaceuticals, Inc. |
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
|
US8722739B2
(en)
*
|
2008-10-29 |
2014-05-13 |
Novaer Holdings, Inc. |
Amino acid salts of prostaglandins
|
JP2012507552A
(ja)
|
2008-10-29 |
2012-03-29 |
アエリエ・ファーマシューティカルズ・インコーポレーテッド |
プロスタグラジンのアミノ酸塩
|
US8623918B2
(en)
|
2008-10-29 |
2014-01-07 |
Novaer Holdings, Inc. |
Amino acid salts of prostaglandins
|
US20100204335A1
(en)
*
|
2008-12-01 |
2010-08-12 |
Allergan, Inc. |
Kit and composition for eyelash growth
|
US20110293549A1
(en)
|
2009-02-03 |
2011-12-01 |
Athena Cosmetics, Inc. |
Composition, method and kit for enhancing hair
|
WO2010112615A1
(en)
|
2009-04-03 |
2010-10-07 |
Dsm Ip Assets B.V. |
Lysine derivatives functionalised with lipids
|
JP2012525386A
(ja)
|
2009-05-01 |
2012-10-22 |
アエリエ・ファーマシューティカルズ・インコーポレーテッド |
疾患の治療のための二重機構阻害剤
|
RU2012115103A
(ru)
|
2009-09-17 |
2013-10-27 |
Сэндзю Фармасьютикал Ко., Лтд. |
Водные глазные капли, содержащие латанопрост, и способ ингибирования адсорбции латанопроста полимером
|
KR101769637B1
(ko)
*
|
2009-11-09 |
2017-08-18 |
알러간, 인코포레이티드 |
모발 성장을 촉진하기 위한 조성물 및 방법
|
US9149484B2
(en)
|
2009-11-09 |
2015-10-06 |
Allergan, Inc. |
Compositions and methods for stimulating hair growth
|
EP2389939A1
(en)
|
2010-05-28 |
2011-11-30 |
Novagali Pharma S.A. |
Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
|
US9522153B2
(en)
|
2009-12-22 |
2016-12-20 |
Allergan, Inc. |
Compositions and methods for lowering intraocular pressure
|
AU2010358560B2
(en)
|
2010-08-02 |
2015-02-12 |
Ac Patent Holding Inc. |
Composition, method and kit for enhancing hair
|
JP2014500275A
(ja)
|
2010-12-06 |
2014-01-09 |
フォリカ,インコーポレイテッド |
禿頭症を治療するため、および毛髪の成長を促進するための方法
|
ES2687494T3
(es)
|
2011-01-19 |
2018-10-25 |
Topokine Therapeutics, Inc. |
Métodos y composiciones para reducir la grasa corporal
|
US8859616B2
(en)
|
2011-01-21 |
2014-10-14 |
Allergan, Inc. |
Compounds and methods for enhancing hair growth
|
ES2684351T3
(es)
|
2011-02-04 |
2018-10-02 |
Kowa Co., Ltd. |
Terapia farmacológica para prevenir o tratar glaucoma
|
US8426471B1
(en)
|
2011-12-19 |
2013-04-23 |
Topokine Therapeutics, Inc. |
Methods and compositions for reducing body fat and adipocytes
|
HU231203B1
(hu)
|
2011-12-21 |
2021-10-28 |
CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. |
Új eljárás travoprost előállítására
|
WO2013133730A1
(en)
*
|
2012-03-09 |
2013-09-12 |
Instytut Farmaceutyczny |
PROCESS FOR PREPARATION OF PROSTAGLANDIN F2α ANALOGUES
|
CA2869676C
(en)
|
2012-11-21 |
2015-06-23 |
Topokine Therapeutics, Inc. |
Uses and compositions comprising a thiazolidinedione and oleic acid for locally increasing subcutaneous fat
|
HU230744B1
(hu)
|
2012-11-30 |
2018-01-29 |
CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. |
Új eljárás travoprost előállítására
|
CN109528721B
(zh)
|
2013-03-15 |
2021-10-01 |
爱瑞制药公司 |
联合治疗
|
NO2753788T3
(sl)
|
2013-05-10 |
2018-06-16 |
|
|
WO2014186504A1
(en)
|
2013-05-15 |
2014-11-20 |
Topokine Therapeutics, Inc. |
Methods and compositions for topical delivery of prostaglandins to subcutaneous fat
|
JP2017502089A
(ja)
|
2014-01-10 |
2017-01-19 |
マニスティー パートナーズ エルエルシーManistee Partners Llc |
偏頭痛の処置
|
HU231214B1
(hu)
|
2014-03-13 |
2021-11-29 |
CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. |
Új eljárás nagytisztaságú prosztaglandinok előállítására
|
WO2015200425A1
(en)
|
2014-06-27 |
2015-12-30 |
Topokine Therapeutics, Inc. |
Topical dosage regimen
|
MX2020012011A
(es)
*
|
2014-10-15 |
2022-04-19 |
Alcon Inc |
Conjugados y derivados de prostaglandina para tratar el glaucoma y la hipertension ocular.
|
ES2954412T3
(es)
|
2014-10-20 |
2023-11-22 |
Sentiss Pharma Private Ltd |
Solución oftálmica
|
EP3223793B1
(en)
|
2014-11-25 |
2023-06-28 |
Eximore Ltd. |
Compositions and methods for delivering a bio-active agent or bio-active agents
|
US10280138B2
(en)
|
2015-03-31 |
2019-05-07 |
Nicox S.A. |
Nitric oxide donating derivatives of fluprostenol
|
CA2999988C
(en)
|
2015-09-27 |
2024-06-11 |
Follica, Inc. |
Needling device and drug applicator
|
US9643927B1
(en)
|
2015-11-17 |
2017-05-09 |
Aerie Pharmaceuticals, Inc. |
Process for the preparation of kinase inhibitors and intermediates thereof
|
DE102016110381A1
(de)
*
|
2016-06-06 |
2017-12-07 |
Edwin Kohl |
Kosmetische Zusammensetzung, insbesondere zur Förderung des Haarwuchses
|
US11478437B2
(en)
|
2016-07-05 |
2022-10-25 |
Jenivision Inc. |
Formulations for hair growth
|
KR102568082B1
(ko)
|
2016-08-31 |
2023-08-17 |
에어리 파마슈티컬즈, 인코포레이티드 |
안과용 조성물
|
AU2018243687C1
(en)
|
2017-03-31 |
2020-12-24 |
Aerie Pharmaceuticals, Inc. |
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
|
US11427563B2
(en)
|
2018-09-14 |
2022-08-30 |
Aerie Pharmaceuticals, Inc. |
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
|